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Abstract
Background: Recently, there has been a growing concern that the 
indiscriminate use of antimicrobial agents in household, food industry 
and hospitals may contribute to the emergence of bacteria resistant 
to antibiotics.
Aim of the work: To detect any possible link between the susceptibility 
profiles of different clinical and environmental isolates to biocides and 
antibiotics in an Egyptian hospital. 
Methods: Sixty six different microbial isolates were isolated from differ-
ent clinical specimens and different environmental samples obtained 
from a University Hospital in Alexandria. These isolates were screened 
for their susceptibility to 22 broad spectrum antibiotics using disc agar 
diffusion technique. In addition, the susceptibility of the isolates to six 
commonly used biocides was screened through minimum inhibitory 
concentration (MIC) determination by agar dilution technique. Cor-
relations between the obtained data were made through Spearman’s 
correlation using SPSS® statistical program.
Results: Sixty two percent of the isolates were multidrug resistant 
(MDR); and 11% were extremely drug resistant (XDR). On the other 
hand, 34% of the tested isolates were multi-disinfectant reduced sus-
ceptibility (MDRS) isolates. The statistical analysis of our data revealed 
a moderate positive correlation between antibiotic resistance and bio-
cide tolerance (0.376≥; ρ≥0.278; p<0.05). In addition, strong significant 
correlations (p<0.01) were also found between reduced susceptibilities 
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Introduction
Nosocomial infections are recognized as a seri-
ous patient safety issue worldwide; especially with 
the alarming increase in bacterial resistance to most 
of the existing antibacterial agents [1]. The World 
Health Organization (WHO) considered healthcare-
associated infections to be a major problem of hos-
pital treatment which is contributing significantly to 
morbidity and mortality rates  and cost of care [2].
Biocides (antiseptics and disinfectants) are used 
extensively in hospitals and other healthcare set-
tings for a variety of topical and hard-surface ap-
plications. They are an essential part of infection 
control practices and aid in the prevention of noso-
comial infections [3]. 
Biocides used in hospital settings belong to dif-
ferent chemical classes. Those based on quaternary 
ammonium compounds (QACs) such as benzalko-
nium chloride (BK) and cetrimide (CET) are used 
for preoperative skin disinfection and non-critical 
surface disinfection. Chlorhexidine (CHX) which 
belongs to biguanides is extensively used as an 
ingredient in multiple antiseptic and disinfectant 
products especially in combination with QACs such 
as in savlon antiseptic liquid [4, 5]. 
Among the other commonly used classes of bio-
cides are the oxidizing agents such as the chlorine 
releasing agents (CRA) and povidone iodine (PVPI). 
Sodium hypochlorite (household bleach) is widely 
used in hospitals as general disinfectants; especial-
ly for the disinfection of blood spillages. Povidone 
iodine (Betadine®) is the most extensively used an-
tiseptic in the Egyptian hospitals for surgical hand 
disinfection and preoperative skin disinfection [3, 4]. 
Chloroxylenol which is a phenolic compound is 
the main chemical constituent of the commercial 
product Dettol® which is widely used in homes and 
healthcare settings for various purposes including 
disinfection of the skin, objects and equipment  as 
well as environmental surfaces [6]. 
In spite of the extensive use of biocides in hospi-
tals, the incidence of nosocomial infections has not 
decreased, and many outbreaks have been caused 
by multidrug-resistant pathogens [7]. Many reports 
on microbial adaptation and resistance to biocides 
have been emerging [1, 8]. Therefore, there has 
been a growing concern in the recent years that, 
as for antibiotics, intensive exposure of hospital 
pathogens to biocides might result in the emer-
gence of resistance to these agents [1]. 
It is well established that the main cause of the 
development and spread of antibiotic resistance 
within hospitals is the inappropriate widespread use 
and over-prescription of antibiotics in clinical prac-
tice [9]. However, concern has been expressed that 
the indiscriminate use of biocides in general practice 
and especially in the clinical settings may be another 
to multiple biocides such as benzalkonium chloride (BK), cetrimide 
(CET), chlorhexidine (CHX), povidone-iodine (PVPI) and Dettol®. 
Conclusion: The observed association between antibiotic resistance 
and biocides reduced susceptibility may reflect cross-resistance be-
tween biocides and antibiotics used in hospital.
Keywords: Cross-resistance, Correlation, Biocides, Antibiotics, Noso-
comial Infections. 
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contributing factor to the evolution and selection of 
antibiotic resistant strains [1, 3, 4, 10, 11]. 
This study aimed to investigate the relation-
ship between biocide use and antibiotic resistance 
among common bacteria species in the Egyptian 
hospitals. 
Material and Methods
The protocol of this study was approved by the 
Council of Postgraduate studies in Faculty of Phar-
macy and in Alexandria University, Egypt.
Microorganisms Standard strains  
The standard strains used in this study were:
Staphylococcus aureus ATCC 6538, S. aureus 
ATCC 12600, Staphylococcus epidermidis ATCC 
12228, Escherichia coli ATCC 8739, E. coli NCTC 
10418, Enterococcus faecalis ATCC 29212, Klebsi-
ella pneumoniae ATCC 13883, Pseudomonas aeru-
ginosa ATCC 9027, Candida albicans ATCC 10231, 
Micrococcus luteus ATCC 9341.
Bacterial isolates
A total of 66 bacterial isolates were included in 
this study. These were classified into:
Clinical isolates
Forty-one clinical isolates were collected from dif-
ferent clinical specimens: infected surgical wounds, 
sputum, blood, pus, infected bed sores, urine, in-
fected leg ulcer and inter costal tube drainage. The 
isolates were obtained from inpatients who ac-
quired nosocomial infections in the intensive care 
unit (ICU), the high dependency unit (HDU); and 
wards in the main University Hospital, Faculty of 
Medicine, Alexandria University by the help of the 
medical staff. 
The clinical isolates were classified into 27 Gram 
negative and 14 Gram positive strains. These were 
identified by classical microscopy and biochemical 
methods as follows: 14 Pseudomonas  aeruginosa, 
5 Acinetobacter baumannii, 1 E. coli, 6 Klebsiella 
spp., 1 Proteus mirabilis, 6 S. aureus, 5 S. epidermi-
dis, 2 E. faecalis and 1 E. faecium. 
Environmental isolates
A total of 25 environmental isolates were also 
included in this study. These were isolated from 
different samples obtained from the hospital envi-
ronment. Samples were collected from settle plates 
placed in: the operation theatre of emergency de-
partment, the HDU, and the operation theatre of 
the surgery department. In addition, swabs were 
taken from the surface of the dressing table, the 
sink in the HDU, and the bacterial filtration of 
chlorine waste solution used for disinfection of 
the wards .The environmental isolates were classi-
fied into 11 Gram-negative and 14 Gram-positive 
organisms. These were identified at least to the 
genus level using Gram-stain microscopy and bio-
chemical methods as follows: 8 Acinetobacter spp., 
3 Klebsiella spp., 3 S. aureus, 6 coagulase negative 
staphylococci (CoNS), 2 Micrococcus spp., 2 Gram 
positive rods and 1 C. albicans. The E. coli, P. mira-
bilis and all Klebsiella spp. Isolates were  grouped 
as Enterobacteriaceae. Also, all staphylococci iso-
lates which showed coagulase-negative test were 
grouped as non-coagulase staphylococci (CONS). 
This group included the clinical S. epidermidis iso-
lates.
Culture media 
Nutrient agar and broth (LAB M Ltd, UK), Müller 
-Hinton agar and broth (LAB M Ltd, UK)
Biocides
Benzalkonium chloride powder (Pharco pharma-
ceutical Co., Egypt), Cetrimide (Alexandria Co. for 
Pharmaceuticals, Egypt);, Chlorhexidine diacetate 
(Synochem Präparate, Germany), Chlorine releas-
ing agent was purchased as Clorox® which con-
tains 5% sodium hypochlorite (Clorox Co., Egypt), 
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Dettol® which contains Chloroxylenol BP 4.8% w/v 
(Royal Cosmetic Co., Reckitt Benckiser, Egypt), Po-
vidone Iodine was purchased as Betadine® (10%) 
(Nile Pharm. and Chem. Ind. Co., Egypt).
Antibiotics 
All antibiotic discs were obtained from BIOANAL-
YSE, Turkey. 
Amikacin (AK), ampicillin/sulbactam (SAM), az-
treonam (ATM), carbenicillin (PY), cefepime (FEP), 
cefoperazone (CEP), cefotaxime (CTX), ceftazidime 
(CAZ), ceftriaxone (CRO), cephradine (CE), cefu-
roxime (CXM), chloramphenicol (C), ciprofloxacin 
(CIP), doxycycline (DO), erythromycin (E), gentami-
cin (CN), imipenem (IPM), levofloxacin (LEV), linco-
mycin (L), oxacillin (OX), rifampin ( RA), tetracycline 
(TE), vancomycin (VA).
Isolation of microorganisms from air by 
passive air sampling techniques using 
settle plates  
Three sterile and pre-incubated nutrient agar 
plates with a diameter of 9 cm each were left open 
exposed to air to collect aerobic microorganisms in 
air which sediment out on the surface of the agar 
plates. One plate was placed in each of the follow-
ing mentioned places: the HDU, an operation the-
atre in the Surgery department; and an operation 
theatre in the Emergency department. The settle 
plates in operation theatres were placed during op-
eration according to 1/1/1 scheme (for 1 hr, 1 m 
above the floor, about 1 m away from walls or any 
major obstacles) [12]. The plates were then closed 
and sent immediately to the laboratory to be incu-
bated at 37°C for 48 hr. 
Determination of the MICs of different 
biocides
The MICs of 6 biocides: BK, CHX, CET, hypochlo-
rite solution Clorox®, PVPI (Betadine®) and Dettol® 
were screened for the clinical and environmental 
isolates using the agar dilution technique [13]. The 
MIC50 and MIC90 were calculated for each class of 
tested isolates using the cumulate and interpolate 
method according to Hamilton-Miller [14]. The iso-
lates showing MIC values higher than the MIC50 
were assumed to have disinfectant reduced suscep-
tibility (DRS) isolates. The isolates showing reduced 
susceptibility to more than two biocides were con-
sidered as multiple disinfectant reduced susceptibil-
ity (MDRS) isolates
Antibiotic susceptibility testing of the 
isolates 
The susceptibility of the potentially pathogenic 
isolates to various commonly used broad spec-
trum antibiotics was determined by the standard 
disc agar diffusion technique according to Bauer 
et al.[15] with some modifications [16]. The sus-
ceptibilities of the tested isolates were compared 
to the susceptibility tables published in the Clinical 
and Laboratory Standards Institute (CLSI 2007) and 
the British Society of Antimicrobial Chemotherapy 
(BSAC version 10) [16, 17]. The isolates were classi-
fied into MDR and XDR according to the published 
international expert proposal for standard defini-
tions for acquired resistance profiles [18].
Statistical analyses 
The obtained data were analyzed using the sta-
tistical program SPSS version 20 (IPM Co., NY, USA). 
The correlations between MIC values for each pair 
of the studied biocides; in addition, the correlations 
between the MIC values of each biocide and the 
percentage of the resistant antibiotics in all isolates 
were determined using Spearman rank correlation 
[19]. The correlation was considered significant 
when the P-value is less than 0.05.
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Results
Antibiotic resistance patterns 
Sixty-two percent of the tested isolates were 
MDR and 11% were XDR [18]. The clinical isolates 
were found to be more resistant to antibiotics than 
the environmental isolates (Figures 1 and 2). 
Cefotaxime and ceftriaxone were the least ac-
tive antibiotics against the Gram-negative isolates 
followed by ampicillin/ sulbactam and tetracycline 
(the percentages of resistant isolates were 92.6%, 
92.6%, 89% and 85%, respectively). Whereas, the 
most active antibiotic against the clinical Gram-
negative isolates was imipenem (the percentage of 
resistant isolates was 26%) (Figure 1). 
In general, the antibiotics which percentage of 
resistant isolates exceeded 50% were aztreonam, 
chloramphenicol, ceftazidime, cefoperazone, cip-
rofloxacin, gentamicin, ceftriaxone, cefotaxime, 
doxycycline, cefepime, carbenicillin, ampicillin/sul-
bactam and tetracycline for the clinical Gram-neg-
ative isolates. The corresponding antibiotics for the 
environmental Gram-negative isolates were ceftri-
axone, cefotaxime, carbenicillin and ampicillin/sul-
bactam (Figure 1).
Similarly, the environmental Staphylococcus iso-
lates were less resistant to antibiotics than the clini-
cal isolates (Figure 2). The percentage of oxacillin 
resistance among the clinical staphylococci isolates 
was about 90.9% versus 44.4% among the envi-
ronmental isolates. No vancomycin resistance was 
observed among the tested isolates. It can be no-
ticed that ceftazidime, cefotaxime and ceftriaxone 
were the least active antibiotics against the clinical 
Gram-positive isolates followed by oxacillin and ce-
fotaxime; the percentage of resistant isolates were 
100%, 100%, 100%, 92.9% and 92.9% respec-
tively. 
In general, the antibiotics which percentage of 
resistant isolates exceeded 50% were ceftazidime, 
gentamicin, ceftriaxone, cefotaxime, doxycycline, 
erythromycin, cefepime, lincomycin, oxacillin and 
tetracycline for the clinical Gram-positive isolates. 
The corresponding antibiotics for the environmen-
Figure 1. Frequency of antibiotic resistance among the Gram negative isolates. The dashed line indicates resistance among 50% of the 
tested isolates. Cl: Clinical isolates. Env: Environmental isolates.
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2014
Vol. 4 No. 4:4
doi: 10.3823/761
This article is available from: www.iajaa.org   /   www.medbrary.com6
tal Gram-positive isolates were ceftazidime, genta-
micin, ceftriaxone, cefotaxime, and erythromycin 
(Figure 2).
The susceptibilities of the collected 
isolates to the tested biocides
In order to determine the relative susceptibilities 
of the collected clinical and environmental isolates 
to the tested biocides, the MIC values of the tested 
isolates were compared to those obtained for the 
corresponding standard strains which were used as 
control (Table 1).
It can be noticed from the MIC ranges pre-
sented in Table 2 that the Gram-negative iso-
lates were much more insusceptible to BK, CHX, 
CET and Dettol® than the Gram- positive ones. 
On the other hand, there was no considerable 
difference in the susceptibilities of Gram-positive 
and Gram-negative isolates towards CRA (Clo-
rox®) and PVPI (Betadine®), however, the Gram-
negative isolates were slightly more insusceptible 
towards PVPI. In General, it was noticed that the 
source of the isolates; whether being clinical or 
environmental, did not significantly influenced 
the susceptibility to biocides within the same 
class of organisms. It was also noticed that P. ae-
ruginosa and some A. baumannii clinical isolates 
were the most insusceptible organisms towards 
multiple biocides; BK, CHX and CET. The MIC50 
and MIC90 was calculated for each class of test-
ed isolates according to the cumulate and inter-
polate method and were listed in Table 2 [14]. 
About 32% of the tested Gram negative isolates 
were considered MDRS isolates. 
Correlation between the MIC values of 
biocides and the percentage of resistant 
antibiotics
The MICs of BK for each isolate were correlated 
with those of CET. The obtained Spearman’s cor-
relation coefficient (ρ 0.951, N=66) which was 
significant at 0.01 level indicated very strong cor-
relation between the two QACs; BK and CET. Very 
strong significant correlations were also found be-
tween the MIC values of the following pairs of bio-
cides: BK and CHX (ρ 0.801, p<0.01, N=66); CET 
and CHX (ρ 0.801, p<0.01, N=66); BK and PVPI (ρ 
0.811, p<0.01, N=66). 
Figure 2. Frequency of antibiotics resistance among the Gram positive isolates. The dashed line indicates resistance among 50% of the 
tested isolates. Cl: Clinical isolates. Env: Environmental isolates.
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Table 1. The MICs of biocides against the standard strains* 
Standard Strains
MIC (mg/L)
BK CHX CET CRA PVPI Dettol
P. aeruginosa  ATCC 9027 100 12.5 100 937.5 1250 150
K. pneumoniae  ATCC 13883 50 12.5 50 625 2500 150
E. coli  ATCC 8739 50 3.125 50 625 2500 150
E. coli   NCTC 10418 50 4.68 50 937.5 2500 150
S. aureus   ATCC 6538       1.56 1.56 1.56 1250 1250 37.5
S. aureus   ATCC 12600 3.125 1.56 3.125 1250 1250 37.5
S. epidermidis ATCC 12228 0.78 1.56 0.78 625 1250 75
M. luteus ATCC 9341 0.78 1.56 1.56 156.25 1250 37.5
E. faecalis  ATCC 29212 6.25 3.125 4.7 234.4 937.5 37.5
C. albicans ATCC 10231 6.25 3.125 3.125 1250 1250 37.5
Acinetobacter spp. (A)* 25 10 ND ND ND ND
The average MICs of BK and CHX for Acinetobacter spp. published in the literature [20]. ND: Not determined.
Table 2.  The ranges of MIC values, MIC50 and MIC90 for the different classes of tested isolates 
(categorization was based on the MIC50)
                   Biocides
Organisms
Range of MICs (mg/L) 
(MIC50/ MIC90) 
BK CHX CET CRA PVPI Dettol®
Pseudomonas spp.
75->400* 
(200/400)**
6.25->200 
(12.5/25)
75->400 
(200/400)
312.5-1250 
(625/125)
1250-2500 
(2500/2500)
150-300 
(150/300)
Acinetobacter spp.
12.5->400 
(25/400)
1.56-150 
(12.5/50)
6.25-400 
(50/400)
234.4-625 
(312.5/625)
1250-2500 
(1250/2500)
37.5-150 
(75/150)
Enterobacteriaceae
25-200 
(50/200)
3.125-50 
(25/50)
25-200 
(75/200)
625-1250 
(937.5/1250)
1250-3750 
(2500/2500)
37.5-150 
(150/150)
S. aureus
1.56-12.5 
(3.125/12.5)
1.56-3.125 
(2.3/6.25)
3.125-6.25 
(3.125/6.25)
468.75-1875 
(1250/1875)
625-1250 
(937.5/1250)
18.75-75 
(56.25/75)
CoNS
0.78-12.5 
(3.125/6.25)
0.39-4.7 
(1.56/2.3)
0.78-9.4 
(1.56/12.5)
156.25-1250 
(625/1250)
312.5-1250 
(937.5/1250)
14.1-75 
(56.25/75)
Enterococcus spp. 3.125-6.25 3.125-6.25 3.125-4.7 625-1875 1250 -1250 56.5-75
C. albicans 3.125 1.56 4.7 156.25 625 9.375
* Range of MICs of BK against Pseudomonas isolates in mg/L.
** MIC50 and MIC90 of BK against Pseudomonas isolates in mg/L by cumulate and interpolate method.
THE INTERNATIONAL ARABIC JOURNAL OF ANTIMICROBIAL AGENTS
ISSN 2174-9094
2014
Vol. 4 No. 4:4
doi: 10.3823/761
This article is available from: www.iajaa.org   /   www.medbrary.com8
A strong correlations were based on the result of 
Spearman’s correlation coefficients and these were 
recorded between the following pairs of biocides: 
CET and Dettol® (ρ 0.794, p<0.01, N=66); BK and 
Dettol® (ρ 0.791; p<0.01, N=66); PVPI and Dettol® 
(ρ 0.783; p<0.01, N=66); CET and PVPI (ρ 0.759; 
p<0.01, N=66); CHX and PVPI (ρ 0.721, p<0.01, 
N=66); CHX and Dettol® (ρ 0.599; p<0.01, N=66). 
The correlation coefficients revealed moderate but 
significant correlations between: CRA and PVPI (ρ 
0.376; p<0.05, N=66); CRA and Dettol® (ρ 0.395; 
p<0.01, N=66). On the other hand, the correlations 
between CRA and the following biocides; BK, CHX 
and CET were low and insignificant at 0.05 level.
Furthermore, the MIC values of each of the test-
ed biocides were correlated with the percentage 
of the resistant antibiotics to all isolates (calculated 
from the data presented in the supplementary ta-
bles) using Spearman’s correlation. The correlation 
coefficients (Table 3) revealed moderate but sig-
nificant (p<0.05) correlations between the percent-
age of the resistant antibiotics and the MICs of the 
following biocides: BK (ρ 0.278; p<0.05), CHX (ρ 
0.376; p<0.01), CET (ρ 0.310; p<0.05) and PVPI (ρ 
0.325; p<0.05). On the contrary, the correlations of 
the MICs of CRA and Dettol® with antibiotic resis-
tance were low and insignificant at 0.05 level.
Discussion
The hospital environment is a potential reservoir 
of infectious agents since most patients carried 
normally in their intestine diverse pathogenic and 
highly resistant microorganisms. Moreover, the an-
tibiotics, especially the broad spectrum types and 
the biocides are extensively used in hospitals [21]. 
This fact reflects why hospitals are suitable to exam-
ine the correlation between biocides susceptibility 
and antibiotics resistance among microoganisms.
The alarming increase in antimicrobial resistance 
rates among bacterial isolates is a real challenge 
currently facing the clinical practice in Egypt. Broad 
spectrum antibiotics such as aztreonam, carbapen-
ems, third and fourth generation cephalosporins, 
penicillin/β-lactamase inhibitors and quinolones are 
extensively and often empirically prescribed in the 
Egyptian hospitals. This may explain the occurrence 
of significant resistance to some broad spectrum 
antibiotics such as ceftriaxone and cefotaxime and 
the high prevalence of MDR among the isolates.
Although it has reported that the assessment 
of antibacterial activity of biocides by bactericidal 
testing is more relevant than bacteriostatic testing 
[4]. When a large number of strains are required 
for testing, the MIC determination is considered a 
Table 3.  Correlation between MIC values of each biocide and the percentages of resistant antibiotics in 
all screened isolates
Biocides/ Resistant 
Antibiotics(AB)
Spearman’s Correlation Coefficient 
 (ρ) P-value N 
BK / AB 0.278 0.03 61
CHX / AB 0.376 0.003 61
CET / AB 0.310 0.015 61
CRA / AB 0.215 0.096 61
PVPI / AB 0.325 0.011 61
Dettol® / AB 0. 243 0.060 61
P-value: Significance (2-tailed). N: degrees of freedom.
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time effective method [22]. In addition, it has been 
extensively used by many researchers for screen-
ing the biocide susceptibility of a large number of 
isolates [20, 22-26]. Agar dilution was the most 
convenient technique for MIC determination in the 
present work since most of the tested biocides; es-
pecially QACs, CHX and Dettol® produced cloudy 
precipitate in the culture media at relatively high 
concentrations (≥100 mg/L for QACs and CHX), 
whereas the inspection of the bacterial growth in 
liquid culture media by turbidity would be  difficult 
to assessed  [3, 22]. 
The ranges of MICs for the tested classes of or-
ganisms in this work were comparable to those ob-
tained by other researchers [20, 23, 24]. For exam-
ple, Koljalg et al. found that the range of CHX MICs 
for the Gram-positive isolates was much less than 
those of Gram- negative isolates. The non-fermen-
tative bacteria; P. aeruginosa and A. baumannii iso-
lates showed the highest CHX MIC and minimum 
bactericidal concentration (MBC) values among the 
60 tested Gram-positive and Gram-negative iso-
lates [27]. Since there was no definite international 
MIC breakpoints for biocides and those published 
in the literature were so variable, thus the interpre-
tation of the obtained MIC values was considered 
relative to the MIC50. A comparable approach was 
previously adopted by Kawamura-Sato et al. in de-
termining the relative susceptibilities of the tested 
Acinetobacter isolates towards the biocides [20]. 
Most infection control practitioners emphasize 
the use of high concentrations of disinfectants ac-
cording to their MICs. Generally, it is recommended 
that the in-use concentrations of disinfectants to be 
100-1000 times greater than their MICs, since this 
method would prevent bacteria to overcome the 
rapid damage and to develop resistance [28]. Gen-
erally, QACs and CHX are used as aqueous or alco-
holic solutions in hospitals. The in-use concentra-
tion of QACs is usually between 1100 - 2000 mg/L 
and that of CHX is often 5000 mg/L as reported 
by many studies [5, 20, 29]. These concentrations 
are generally used for hand hygiene and the disin-
fection of non-critical items including medical de-
vices. In addition, this concentration of CHX is usu-
ally used in preoperative skin antisepsis [20]. The 
centres for Disease Control and Prevention in USA 
recommend 1:100 dilution of household bleach 
(hypochlorite solution) for disinfection in health-
care settings. This method would be equivalent to 
500 mg/L [5]. It is reported that the best dilution of 
10% povidone-iodine is 100 folds and this would 
be equivalent to 1000 mg/L [5]. The recommended 
dilutions of Dettol® by the manufacturer for medi-
cal uses are 1:20 for cuts and abrasions; and 1:40 
for midwifery which is corresponding to 2400mg/L 
and 1200 mg/L , respectively.
Certain MICs in the present work, especially 
those for the non-fermentative Gram- negative 
isolates, were found to be very close to the rec-
ommended in-use concentrations of the biocides 
in hospitals. Therefore, the recommended 100 fold 
difference between the in-use concentrations and 
the obtained MIC values of the biocides were not 
achieved in many cases.  The very strong and sig-
nificant correlation between the MICs of BK and 
CET can be attributed to the fact that these two 
agents belong to the same class (QACs) on the ba-
sis of chemical structure and mode of action. The 
strong positive correlations between the QACs and 
CHX may be due to the similarity of their mecha-
nisms of action, as both of them are predominantly 
membrane active agents. Similarly, significant posi-
tive correlations were obtained by Kawamura-Sato 
et al. who tried to correlate the MICs of different 
biocides for 283 clinical Acinetobacter isolates. The 
values of Spearman rank correlation coefficient 
were found to be  0.631 for BK and benzethonium 
chloride which is another QAC and 0.632 for BK 
and CHX gluconate. Both correlations were signifi-
cant at 0.01 level [20]. 
The other high and significant correlations 
shown between different classes of biocides for 
which chemical structures and modes of action are 
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dissimilar suggested that general rather than spe-
cific mechanisms of resistance may be involved in 
reducing biocide susceptibility showed by the MDR 
isolates.
The correlation between the MIC values of BK, 
CHX, CET, PVPI and the percentage of antibiotic 
resistant among the tested isolates revealed mod-
erate positive correlations that ranged between 
0.376- 0.278 and were significant at 0.05 level. 
However, the correlations of the MICs of CRA and 
Dettol® with antibiotic resistance were weak and 
insignificant. Similarly, Koljalg et al. found a good 
correlation between CHX and antibiotic suscepti-
bilities in both Gram-negative and Gram-positive 
isolates, since the Spearman’s correlation coeffi-
cients between the MICs of the investigated antibi-
otics and CHX susceptibility ranged between 0.32-
0.67 [27]. The results of Kawamura-Sato et al. also 
showed that MICs of CHX and BK disinfectants 
were well correlated with three tested antimicrobi-
al agents; ceftazidime, amikacin and ciprofloxacin 
(p< 0.05),and  where the Spearman’s correlation 
coefficients ranged between 0.336-0.189 [20]. 
Furthermore, Stickler et al. found strong significant 
positive correlations between MDR (tested by disc 
agar diffusion methods) and the MICs of three cat-
ionic antibacterial agents; CHX, CET and BK. Their 
correlation coefficients ranged between 0.7- 0.9 
(p< 0.05). However, such correlation was not es-
tablished with Hycolin® (a product containing chlo-
roxylenol as active ingredient) [30].
Conclusions
The present study revealed a moderate positive 
correlation between antibiotic resistance and bio-
cide tolerance among hospital bacterial isolates. 
This result should encourage the medical stuff in 
hospitals to be aware of the problem of cross-re-
sistance between biocides and antibiotics, and the 
risk of developing resistance following   inappropri-
ate use of biocides dilutions. 
There is no conflict of interest.
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